Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Shona Livingstone"'
Autor:
Bruce Guthrie, Gabriel Rogers, Shona Livingstone, Daniel R Morales, Peter Donnan, Sarah Davis, Ji Hee Youn, Rob Hainsworth, Alexander Thompson, Katherine Payne
Publikováno v:
Health and Social Care Delivery Research, Vol 12, Iss 04 (2024)
Background Clinical guidelines commonly recommend preventative treatments for people above a risk threshold. Therefore, decision-makers must have faith in risk prediction tools and model-based cost-effectiveness analyses for people at different level
Externí odkaz:
https://doaj.org/article/30d342365251415897ae57b21590bb2d
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Prediction of lifetime cardiovascular disease (CVD) risk is recommended in many clinical guidelines, but lifetime risk models are rarely externally validated. The aim of this study was to externally validate the QRiskLifetime inci
Externí odkaz:
https://doaj.org/article/e9724ac205724de384c175f8e0a78ae9
Autor:
Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, Michael Heinrich, Domingo A. Pascual-Figal, Shona Livingstone, Sajid Abaidullah
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Curcumin, quercetin, and vitamin D3 (cholecalciferol) are common natural ingredients of human nutrition and reportedly exhibit promising anti-inflammatory, immunomodulatory, broad-spectrum antiviral, and antioxidant activities.Objective:
Externí odkaz:
https://doaj.org/article/c4ebbb9b70a445e286b41299604d771f
Autor:
Somia Iqtadar, Amjad Khan, Sami Ullah Mumtaz, Shona Livingstone, Muhammad Nabeel Akbar Chaudhry, Nauman Raza, Mehreen Zahra, Sajid Abaidullah
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 8, Iss 1, p 43 (2023)
Dengue is a mosquito-borne flaviviral serious febrile illness, most common in the tropical and subtropical regions including Pakistan. Vitamin D is a strong immunomodulator affecting both the innate and adaptive immune responses and plays a pivotal r
Externí odkaz:
https://doaj.org/article/1f098b41b52240189788ea341b495517
Autor:
Shona Livingstone, MSc, Daniel R Morales, PhD, Peter T Donnan, ProfPhD, Katherine Payne, ProfPhD, Alexander J Thompson, PhD, Ji-Hee Youn, PhD, Bruce Guthrie, ProfPhD
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 6, Pp e352-e361 (2021)
Summary: Background: Primary prevention of cardiovascular disease (CVD) is guided by risk-prediction tools, but these rarely account for the risk of dying from other conditions (ie, competing mortality risk). In England and Wales, the recommended ris
Externí odkaz:
https://doaj.org/article/f252feb68d0e44b095bf41606e9775d4
Autor:
Harshal A. Deshmukh, Helen M. Colhoun, Toby Johnson, Paul M. McKeigue, D. John Betteridge, Paul N. Durrington, John H. Fuller, Shona Livingstone, Valentine Charlton-Menys, Andrew Neil, Neil Poulter, Peter Sever, Denis C. Shields, Alice V. Stanton, Aurobindo Chatterjee, Craig Hyde, Roberto A. Calle, David A. DeMicco, Stella Trompet, Iris Postmus, Ian Ford, J. Wouter Jukema, Mark Caulfield, Graham A. Hitman
Publikováno v:
Journal of Lipid Research, Vol 53, Iss 5, Pp 1000-1011 (2012)
We carried out a genome-wide association study (GWAS) of LDL-c response to statin using data from participants in the Collaborative Atorvastatin Diabetes Study (CARDS; n = 1,156), the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT; n = 895), and th
Externí odkaz:
https://doaj.org/article/0e30b62ae4ad49fe9ad70c633f99fac3
Publikováno v:
Livingstone, S, Morales, D R, Fleuriot, J D, Donnan, P T & Guthrie, B 2023, ' External validation of the QLifetime cardiovascular risk prediction tool : population cohort study ', Bmc cardiovascular disorders, vol. 23, no. 1, 194, pp. 194 . https://doi.org/10.1186/s12872-023-03209-8
Background Prediction of lifetime cardiovascular disease (CVD) risk is recommended in many clinical guidelines, but lifetime risk models are rarely externally validated. The aim of this study was to externally validate the QRiskLifetime incident CVD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc40a2fd45c9e229d408cbfbd3eea82d
https://hdl.handle.net/20.500.11820/d6be98c3-dc69-4854-9c40-b4f35577c589
https://hdl.handle.net/20.500.11820/d6be98c3-dc69-4854-9c40-b4f35577c589
Autor:
Katherine Payne, Daniel R. Morales, Bruce Guthrie, Ji-Hee Youn, Alexander J. Thompson, Peter T. Donnan, Shona Livingstone
Publikováno v:
The Lancet. Healthy Longevity
The Lancet. Healthy Longevity, Vol 2, Iss 6, Pp e352-e361 (2021)
Livingstone, S, Morales, D R, Donnan, P T, Payne, K, Thompson, A J, Youn, J-H & Guthrie, B 2021, ' Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity : external validation population cohort study ', Lancet Healthy Longevity, vol. 2, no. 6, pp. e352-e361 . https://doi.org/10.1016/S2666-7568(21)00088-X
The Lancet. Healthy Longevity, Vol 2, Iss 6, Pp e352-e361 (2021)
Livingstone, S, Morales, D R, Donnan, P T, Payne, K, Thompson, A J, Youn, J-H & Guthrie, B 2021, ' Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity : external validation population cohort study ', Lancet Healthy Longevity, vol. 2, no. 6, pp. e352-e361 . https://doi.org/10.1016/S2666-7568(21)00088-X
Background: Primary prevention of cardiovascular disease (CVD) is guided by risk-prediction tools, but these rarely account for the risk of dying from other conditions (ie, competing mortality risk). In England and Wales, the recommended risk-predict
Autor:
Paul M. McKeigue, Eva Lahnsteiner, Shona Livingstone, Helen C. Looker, Helen M. Colhoun, Stuart J. McGurnaghan, Bassam Farran
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:1527-1533
Purpose To demonstrate a modelling approach that controls for time-invariant allocation bias in estimation of associations of outcome with drug exposure. Methods We show that in a model that includes terms for both ever-exposure versus never-exposure
Autor:
Shona Livingstone, Helen M. Colhoun, John R. Petrie, Naveed Sattar, Jeremy Walker, Rory J. McCrimmon, Sarah H. Wild
Publikováno v:
Diabetologia
2018, ' Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012–2014): population-based observational study ', Diabetologia . https://doi.org/10.1007/s00125-017-4478-x
2018, ' Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012–2014): population-based observational study ', Diabetologia . https://doi.org/10.1007/s00125-017-4478-x
Aims/hypothesis The aim of this study was to assess the role of socioeconomic status (SES) in the associations between type 2 diabetes and life expectancy in a complete national population. Methods An observational population-based cohort study was p